Chris Phillips has over 4 decades of pharmaceutical CMC experience ranging from R&D to cGMP manufacturing for small molecules, native proteins and biotechnology drug substances and drug products. Previously, Chris was Vice President of Formulation Development and Manufacturing at Aclaris Therapeutics, Inc. He led CMC activities related to the FDA approvals for 2 BLAs and 2 NDAs. He is an inventor on 14 issued US patents.
Leadership
